These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8069012)

  • 21. Erythropoietin: receptors and clinical use in rheumatoid arthritis.
    Krantz SB; Sawyer ST; Sawada K; Wolfe F; Bocagno J
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():181-95; discussion 195-8. PubMed ID: 2157776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction of anemia using self-administered daily subcutaneous erythropoietin in uremic patients on continuous ambulatory peritoneal dialysis.
    Li PK; Leung CB; Lui SF; Leung JC; Shek AC; Lai KN
    Int J Artif Organs; 1993 Jul; 16(7):510-4. PubMed ID: 8370605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures.
    Peeters HR; Jongen-Lavrencic M; Bakker CH; Vreugdenhil G; Breedveld FC; Swaak AJ
    Rheumatol Int; 1999; 18(5-6):201-6. PubMed ID: 10399796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes.
    Ghio R; Balleari E; Ballestrero A; Gatti AM; Mareni C; Massa G; Patrone F; Sessarego M; Timitilli S
    Acta Haematol; 1993; 90(2):58-64. PubMed ID: 8285019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Chung WW; Leung CB; Chan K; Lai KN
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical use of serum erythropoietin determination by the recombigen EPO RIA kit].
    Masaki Y; Oka N; Furuya H; Ohguni S; Takagi C; Sato T; Notsu K; Kato Y
    Kaku Igaku; 1992 Jun; 29(6):701-7. PubMed ID: 1640656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A; Paoletti E; Molinelli G
    Adv Perit Dial; 1990; 6():292-5. PubMed ID: 1982830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
    Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
    J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of recombinant human erythropoietin on anemia caused by a murine mammary carcinoma.
    Mac Manus MP; Elder GE; Abram WP; Bridges JM
    Exp Hematol; 1990 Aug; 18(7):848-52. PubMed ID: 2379551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
    Shih LY; Huang JY
    Nephron; 1998; 79(2):142-7. PubMed ID: 9647492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunoassay for erythropoietin using anti-recombinant erythropoietin antibody with high affinity.
    Matsubara K; Yoshimura T; Kamachi S; Fukushima M; Hino M; Morii H
    Clin Chim Acta; 1989 Nov; 185(2):177-84. PubMed ID: 2624997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin acts as a trophic factor in neonatal rat intestine.
    Juul SE; Ledbetter DJ; Joyce AE; Dame C; Christensen RD; Zhao Y; DeMarco V
    Gut; 2001 Aug; 49(2):182-9. PubMed ID: 11454792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythroid abnormalities in rheumatoid arthritis: the role of erythropoietin.
    Remacha AF; Rodríguez-de la Serna A; García-Dié F; Geli C; Díaz C; Gimferrer E
    J Rheumatol; 1992 Nov; 19(11):1687-91. PubMed ID: 1491387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies.
    Means RT; Olsen NJ; Krantz SB; Dessypris EN; Graber SE; Stone WJ; O'Neil VL; Pincus T
    Arthritis Rheum; 1989 May; 32(5):638-42. PubMed ID: 2719734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The efficacy and safety of continuous erythropoietin receptor activator in dialytic patients with chronic renal anemia: an open, randomized, controlled, multi-center trial].
    Chen N; Qian JQ; Mei CL; Zhang AH; Xing CY; Wang L; Liu WH; Wang M; Chen JH; Liu BC; Hou FF; Chen XM; Zuo L; Shi W; Yu LB; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):502-7. PubMed ID: 22943819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia.
    Bessho M; Jinnai I; Matsuda A; Saito M; Hirashima K
    Int J Cell Cloning; 1990 Nov; 8(6):445-58. PubMed ID: 2273298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.